The FDA's Fast Track programme is designed to facilitate the development of new drugs that have shown the potential to address an unmet medical need in a serious or life-threatening disease. Fast Track designated drugs ordinarily qualify for Priority Review, an expedited review process available to drugs that offer major advances in treatment or provide a treatment where no adequate therapy exists.
Glyn Edwards, CEO of Antisoma, said "We're very pleased to have gained FDA Fast Track status for AS1413. This drug could represent a major advance in the options available to patients with secondary AML, and we look forward to completing the ongoing phase III trial and sharing the data with FDA and other regulators."
AS1413 already has orphan drug status in both the U.S. and the E.U. for the treatment of AML.
Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828
Recent ASM News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/28/2024 11:45:24 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/08/2023 10:06:09 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 10/30/2023 10:30:20 AM
- AVINO ANNOUNCES Q2 2023 PRODUCTION RESULTS • PR Newswire (Canada) • 07/20/2023 10:45:00 AM
- AVINO ANNOUNCES Q2 2023 PRODUCTION RESULTS • PR Newswire (US) • 07/20/2023 10:45:00 AM
- AVINO DRILLS BEST INTERCEPT IN COMPANY HISTORY • PR Newswire (US) • 07/05/2023 10:45:00 AM
- AVINO DRILLS BEST INTERCEPT IN COMPANY HISTORY • PR Newswire (Canada) • 07/05/2023 10:45:00 AM
- AVINO RENEWS US ATM SHARE OFFERING • PR Newswire (Canada) • 06/21/2023 09:24:00 PM
- AVINO RENEWS US ATM SHARE OFFERING • PR Newswire (US) • 06/21/2023 09:24:00 PM
- AVINO REPORTS VOTING RESULTS OF ITS 2023 ANNUAL GENERAL MEETING AND APPOINTS NEW DIRECTOR • PR Newswire (Canada) • 06/20/2023 11:18:00 PM
- AVINO REPORTS VOTING RESULTS OF ITS 2023 ANNUAL GENERAL MEETING AND APPOINTS NEW DIRECTOR • PR Newswire (US) • 06/20/2023 11:18:00 PM
- AVINO VEIN EXTENDED A FURTHER 500 METRES • PR Newswire (US) • 05/23/2023 07:45:00 AM
- AVINO VEIN EXTENDED A FURTHER 500 METRES • PR Newswire (Canada) • 05/23/2023 07:45:00 AM
- Avino Reports Q1 2023 Financial Results; Realizes Numerous Operational Achievements • PR Newswire (US) • 05/10/2023 09:48:00 PM
- Avino Reports Q1 2023 Financial Results; Realizes Numerous Operational Achievements • PR Newswire (Canada) • 05/10/2023 09:48:00 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM